Kidney cancer, Renal cell cancer
Results
Phase 3
This trial compared nivolumab (BMS-936558) with everolimus to treat cancer that had grown outside the kidneys or had spread to another part of the body. It was for people with the most common type of kidney cancer called renal cell cancer.
Recruitment start: 9 October 2012
Recruitment end: 1 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Martin Gore
Bristol-Myers Squibb
NIHR Clinical Research Network: Cancer
Last reviewed: 16 May 2016
CRUK internal database number: 9438
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
